SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Pettiti Gianluca | President & COO | 2026-08-31 | Open-market sell 10b5-1 | 400 | $246K |
| Pettiti Gianluca | President & COO | 2026-08-31 | Option exercise 10b5-1 | 3733 | $1.2M |
| Pettiti Gianluca | President & COO | 2026-08-31 | Open-market sell 10b5-1 | 3733 | $2.3M |
| Britt Lisa P. | Sr. VP and Chief HR Officer | 2026-08-28 | Tax withholding | 87 | $54K |
| Britt Lisa P. | Sr. VP and Chief HR Officer | 2026-08-28 | Tax withholding | 116 | $72K |
| Britt Lisa P. | Sr. VP and Chief HR Officer | 2026-08-28 | Tax withholding | 105 | $66K |
| Britt Lisa P. | Sr. VP and Chief HR Officer | 2026-08-28 | Tax withholding | 85 | $53K |
| CASPER MARC N | Chairman & CEO, Director | 2026-08-28 | Tax withholding | 725 | $451K |
| CASPER MARC N | Chairman & CEO, Director | 2026-08-28 | Tax withholding | 532 | $331K |
| Holmes Joseph R. | VP & Chief Accounting Officer | 2026-08-28 | Tax withholding | 11 | $7K |
| Holmes Joseph R. | VP & Chief Accounting Officer | 2026-08-28 | Tax withholding | 13 | $8K |
| Holmes Joseph R. | VP & Chief Accounting Officer | 2026-08-28 | Tax withholding | 11 | $7K |
| Holmes Joseph R. | VP & Chief Accounting Officer | 2026-08-28 | Tax withholding | 15 | $9K |
| Meyer James | Sr. Vice President & CFO | 2026-08-28 | Tax withholding | 37 | $23K |
| Meyer James | Sr. Vice President & CFO | 2026-08-28 | Tax withholding | 44 | $28K |
| Meyer James | Sr. Vice President & CFO | 2026-08-28 | Tax withholding | 20 | $12K |
| Meyer James | Sr. Vice President & CFO | 2026-08-28 | Tax withholding | 55 | $34K |
| Meyer James | Sr. Vice President & CFO | 2026-08-28 | Tax withholding | 114 | $71K |
| Pettiti Gianluca | President & COO | 2026-08-28 | Tax withholding 10b5-1 | 212 | $132K |
| Pettiti Gianluca | President & COO | 2026-08-28 | Tax withholding 10b5-1 | 304 | $189K |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
A 26% surge in outstanding debt to $39.38B is the dominant risk shift, materially elevating leverage and refinancing exposure. Compounding this, AI-related risks expanded across multiple dimensions — competitive positioning, IP infringement, and governance/compliance liability — while macro headwinds moved from hypothetical to realized, with a federal shutdown already impacting customer funding. The risk picture worsened broadly across debt, technology, and geopolitical themes.
3 company-specific · 3 common-mode
Outstanding indebtedness increased 26% from $31.27B to $39.38B year-over-year, materially worsening leverage and refinancing risk.
Our existing and future indebtedness may restrict our investment opportunities or limit our activities and negatively impact our credit ratings. As of December 31, 2025, we had approximately $39.38…
Added concrete example of October 2025 federal shutdown and its actual impact on spending, escalating from hypothetical risk to realized event affecting customer funding.
Demand for some of our products depends on capital spending policies of our customers and on government funding policies. Our customers include pharmaceutical and biotechnology companies…
Significant expansion: added specific consequences (civil/criminal penalties, shareholder lawsuits), supplier conduct liability, and new AI misuse risks with reputational/customer loss impacts.
Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents, business partners or other third parties. We have internal…
Added explicit tariff risk and expanded geopolitical/trade risks with detailed bullet points. Reflects heightened trade policy uncertainty and supply chain vulnerabilities.
THERMO FISHER SCIENTIFIC INC. Economic, political, foreign currency and other risks associated with international sales and operations could adversely affect our results of operations. International…
Escalated AI risk disclosure. Added explicit warning that failure to keep pace with AI developments could adversely affect competitive position and results of operations, plus new R&D investment risk.
Business Risks We must develop new products, adapt to rapid and significant technological change, respond to introductions of new products and services by competitors and maintain quality to remain…
New disclosure of AI/generative AI integration risks to IP infringement and misappropriation, escalating technology-related IP exposure.
Our inability to protect our intellectual property could have a material adverse effect on our business. In addition, third parties may claim that we infringe their intellectual property, and we…
This is a straightforward earnings release for Q2 2026 (quarter ended June 27, 2026) filed on July 23, 2026. The Item 2.02 disclosure announces financial results including revenue of $11.99 billion (10% growth), GAAP diluted EPS of $4.68 (9% growth), and adjusted EPS of $6.03 (13% growth), with the full press release furnished as Exhibit 99.1. Quarterly earnings releases are material to investors and are the canonical example of earnings_release classification.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Thermo Fisher's May 20, 2026 Annual Meeting. The filing reports voting outcomes on three proposals: (1) election of 11 directors to the Board, (2) a non-binding advisory vote on named executive officer compensation that was not approved, and (3) ratification of PricewaterhouseCoopers LLP as independent auditor. The rejection of the say-on-pay proposal is material to investors as it signals shareholder dissatisfaction with executive compensation practices.
View raw filing on EDGAR →